New hope for kidney transplant patients battling BK virus
NCT ID NCT04542733
First seen Nov 01, 2025 · Last updated Jun 02, 2026 · Updated 38 times
Summary
This study tests whether a combination of everolimus with reduced tacrolimus works better than reduced tacrolimus plus leflunomide for treating BK virus infection in kidney transplant recipients. BK virus can harm the new kidney, and current treatments are limited. The trial includes 50 adults whose virus levels remain high despite lowering immunosuppression. The goal is to find a safer, more effective way to control the infection and protect kidney function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
King Chulalongkorn Memorial Hospital
Bangkok, Bangkok, 10330, Thailand
Conditions
Explore the condition pages connected to this study.